Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma
نویسندگان
چکیده
منابع مشابه
PEACILOMYCES INFECTION IN AN IMMUNOCOMPROMISED PATIENT
Paecilomyces sp, is a saprophytic fungus which has rarely been associated with human disease. We report the first case of invasive subcutaneous infection caused by this fungus in a 78-year-old female from Damghan, Iran, with diabetes and chronic renal failure. A biopsy provided an initial diagnosis of the mold in tissue. Multiple positive fungal cultures which were obtained from the biopsie...
متن کاملProposed pharmacological treatments for COVID-19: previously confirmed drugs
Background: The outbreak of severe acute respiratory syndrome coronavirus-2, also called COVID-19, first appeared in December 2019 in Wuhan, China. COVID-19 is an enveloped single-stranded RNA virus, which has affected more than 14 million people around the world and caused a high rate of mortality. It is notable that discovering new drugs and vaccines against SARS-CoV2 is time consuming. ...
متن کاملCNS non-Hodgkin lymphoma in a patient previously treated for systemic Hodgkin disease.
Current therapy for Hodgkin disease has resulted in a 5year survival rate of approximately 90% for individuals with asymptomatic stage I and II disease and nearly a 60% survival rate for those with symptomatic stage IV disease (1 ]. This improvement in survival has created an increase in the number of second malignancies occurring after successful treatment of the original disease, a complicati...
متن کاملIs Aflatoxin More in the Milk of Lactating Mothers Who Have Previously Had COVID-19?
Background: Breast milk provides the ideal nutrition for infants. It has a nearly perfect mix of vitamins, protein, and fat. Breastfeeding has many health benefits for both the mother and infant. Breast milk contains all the nutrients an infant needs in the first six months of life. The present study aimed to measure aflatoxin M1 (AFM1) levels in breast milk and identify nutritional and socio-d...
متن کاملCladribine treatment in two-hour intravenous infusion for previously-treated low grade B-cell lymphoma: a pilot study.
Cladribine is approved to be used in 24-hour continuous infusion for the treatment of low-grade lymphoma by the Ministry of Health, Labor and Welfare in Japan. Pharmacokinetic studies showed that the antitumor activity of cladribine by 2-hour infusion should be comparable to that given by continuous infusion. The safety and anti-tumor activity of short infusion of cladribine was shown in hairy ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Monaldi Archives for Chest Disease
سال: 2021
ISSN: 2532-5264,1122-0643
DOI: 10.4081/monaldi.2021.1867